N-terminal pro-B-type natriuretic peptide (nt-proBNP) is an established marker of heart failure in adult cardiology. We analyzed nt-proBNP in the circulation of fetuses with increased volume load ...
Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment (NT) of its prohormone (proBNP) are related to cardiac function and have emerged as clinically useful tools ...
An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...
In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...
While B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) measures have well-established utility in the diagnosis of acute decompensated congestive heart failure (CHF) as well as ...
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: ...
ANP, BNP, and CNP are proving to be reliable biomarkers for a variety of conditions. Natriuretic peptides mainly consist of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and ...
Nephrologists must consider fluid overload effects when prescribing dialysis, according to a new study. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP), ...
B-type natriuretic peptide is released by cardiac myocytes in response to wall stretch. There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback